Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Kishore V. Seendripu, Ph.D. | MXL Maxlinear, Inc | 13G/A | 6.6% | Dec 31, 2023 | 2y |
| MSD Partners, L.P. | ARKO ARKO Corp. | 13G/A | 6.8% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | MNDY monday.com Ltd. | 13G | 6.6% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | CERS Cerus Corp | 13G/A | 10.8% | Dec 31, 2023 | 2y |
| PUBLIC INVESTMENT FUND | LYV Live Nation Entertainment, Inc. | 13G/A | 5.5% | Dec 31, 2023 | 2y |
| Prof. Ugur Sahin, M.D. | BNTX BioNTech SE | 13G/A | 17.4% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | MTEM Molecular Templates, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | ADXS Advaxis, Inc. | 13G/A | 1.9% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | OKLO Oklo Inc. | 13G | 7.59% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | CTMX CytomX Therapeutics, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | DT Dynatrace, Inc. | 13G | 7.4% | Dec 31, 2023 | 2y |
| Edison Partners Management, LLC | GRSD GRANDSTAND Ltd | 13G/A | 7.59% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | HLVX HilleVax, Inc. Common Stock | 13G/A | 5.99% | Dec 31, 2023 | 2y |
| David Kirn | FDMT 4D Molecular Therapeutics, Inc. | 13G/A | 4.7% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | OBIO Orchestra BioMed Holdings, Inc. | 13G | 1.7% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | HAIN Hain Celestial Group Inc | 13G/A | 7.5% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | LXFR Luxfer Holdings PLC | 13G/A | 6.7% | Dec 31, 2023 | 2y |
| Vellar Opportunities Fund Master, Ltd. | SHFS SHF Holdings, Inc. | 13G/A | 2.08% | Dec 31, 2023 | 2y |
| Aristotle Capital Management, LLC | ELS Equity Lifestyle Properties Inc | 13G | 5.95% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | RL Ralph Lauren Corp | 13G | 5.7% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | SYRE Spyre Therapeutics, Inc. | 13G | 6.2% | Dec 31, 2023 | 2y |
| NOMURA HOLDINGS INC | ETWO E2open Parent Holdings, Inc. | 13G | 5.3% | Dec 31, 2023 | 2y |
| Altai Capital Management, L.P. | SKYH Sky Harbour Group Corp | 13G/A | 36.8% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | RNTX Rein Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Walleye Capital LLC | CXAI CXApp Inc. | 13G | 5.33% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | GLBS Globus Maritime Ltd | 13G/A | 5.51% | Dec 31, 2023 | 2y |
| PURA VIDA INVESTMENTS, LLC | QTRX Quanterix Corp | 13G/A | 2.14% | Dec 31, 2023 | 2y |
| Repertoire Partners LP | BCIC BCP Investment Corp | 13G/A | 7.1% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | CVLT Commvault Systems Inc | 13G/A | 3% | Dec 31, 2023 | 2y |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | DTF Dtf Tax-Free Income 2028 Term Fund Inc | 13G | 6.13% | Dec 31, 2023 | 2y |
| Walleye Capital LLC | GNLN Greenlane Holdings, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Avoro Capital Advisors LLC | BCRX Biocryst Pharmaceuticals Inc | 13G | 6.4% | Dec 31, 2023 | 2y |
| Caledonia (Private) Investments Pty Ltd | FXLV F45 Training Holdings Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | ATRI Atrion Corp | 13G | 6.6% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | FBK FB Financial Corp | 13G/A | 10.1% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | IDA Idacorp Inc | 13G | 5.5% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | GLAC Global Lights Acquisition Corp Ordinary Shares | 13G | 6.38% | Dec 31, 2023 | 2y |
| Access Industries Management, LLC | ZURA Zura Bio Ltd | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | CAL Caleres Inc | 13G | 12.7% | Dec 31, 2023 | 2y |
| Vellar Opportunities Fund Master, Ltd. | OIO OIO Group | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Park West Asset Management LLC | LNSR LENSAR, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| First Euro Investments Limited | MMV MultiMetaVerse Holdings Limited Class A Ordinary Share | 13G | 5.3% | Dec 31, 2023 | 2y |
| Omega Fund VI, L.P. | IMA ImageneBio, Inc. | 13G/A | 4.7% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | SEM Select Medical Holdings Corp | 13G/A | 13.3% | Dec 31, 2023 | 2y |
| Joseph DaGrosa, Jr. | JETMF Global Crossing Airlines Group Inc. | 13G/A | 4.3% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | TXT Textron Inc | 13G/A | 6.9% | Dec 31, 2023 | 2y |
| Charles Liang | SMCI Super Micro Computer, Inc. | 13G/A | 13.9% | Dec 31, 2023 | 2y |
| VIKING GLOBAL INVESTORS LP | PEPG PepGen Inc. | 13G/A | 6.2% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | PTIX Protagenic Therapeutics, Inc.new | 13G/A | 5.13% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | IONS Ionis Pharmaceuticals Inc | 13G | 9.2% | Dec 31, 2023 | 2y |